The Lateral Entry option in 2026 is a strategic academic "bridge" designed by the Pharmacy Council of India (PCI) to help diploma holders upgrade their qualifications to a degree level without repeating foundational coursework. Under this system, a student who has successfully completed the two-year D.Pharma course is considered to have already mastered the basic concepts of pharmaceutical chemistry and pharmaceutics. Therefore, they are permitted to skip the first year of the four-year B.Pharma program and join directly in the third semester. This effectively reduces the total time spent earning a Bachelor’s degree from four years to just three.
The primary eligibility for this fast-track route is the completion of a D.Pharma from a PCI-approved institution with a minimum aggregate score, typically around 50% to 60%. In the 2026 admission cycle, lateral entry is highly competitive because it allows students to enter the professional job market sooner. Candidates usually apply through state-level lateral entry entrance tests (like Haryana LEET or OJEE for Odisha) or via direct merit based on their diploma CGPA. This pathway is particularly popular among students who wish to pursue higher-ranking roles such as Drug Inspector or Formulation Scientist, which specifically require a B.Pharma degree.
Curriculum-wise, the transition is seamless but rigorous. Since lateral entry students join in the second year, they dive straight into core specialized subjects like Physical Pharmaceutics, Pharmaceutical Microbiology, and Pharmaceutical Engineering. While their four-year counterparts spent the first year on general biology and mathematics, the lateral entry students bring a distinct advantage: practical clinical experience. Having already completed their 500 hours of hospital training during their diploma, these students often demonstrate superior hands-on skills in the lab compared to traditional second-year students.
From a financial perspective, the lateral entry option offers a significant Return on Investment (ROI). By saving one full year of study, students also save a full year’s worth of tuition fees, hostel charges, and living expenses, which can amount to a saving of ₹1.5 Lakh to ₹2 Lakh depending on the institution. Furthermore, it allows the student to begin their professional career or pursue an M.Pharma one year earlier, providing a head start in a rapidly evolving 2026 healthcare economy where specialized pharmaceutical expertise is in high demand.
Ultimately, the lateral entry system at Puran Murti Campus ensures that "Vertical Mobility" is accessible to all pharmacy students. It recognizes the hard work put into a diploma and provides a clear, state-approved ladder to reach the highest echelons of the pharmaceutical industry. Whether a student’s goal is to manage a large-scale manufacturing unit or to conduct advanced clinical research, the lateral entry path is the most efficient and cost-effective way to transition from a technician-level role to a fully qualified pharmaceutical engineer.